The English session of the conference call will be held at 9:00 AM on Dec. 4, 2024 Beijing Time ( 8:00 PM U.S. Eastern Time on Dec. 3, 2024) and the Mandarin session of the conference call will be ...

Grappling between fighting through a constant struggle of enduring treatment or entering hospice; preparing to say goodbye — ...

Yale's study reveals that social networks, including friends and acquaintances, influence gut microbiome composition, ...

接《对痛风，我们了解多少？（二）》血尿酸不只是引发痛风，还可以损伤其他脏器。而其中最常见也最重要的是肾脏。尿酸或尿酸结晶沉积可引起三种不同的肾脏疾病：急性尿酸性肾病慢性尿酸盐肾病尿酸性肾结石除此外，还有独特的肾脏疾病，它的重要表现形式就是血尿酸偏高。

Graduate student Than Win sitting in his room next to the equipment he uses to treat himself Nov. 7 in Beyerl Hall at Ball ...

Wells Fargo initiated coverage of Vera Therapeutics (VERA) with an Overweight rating and $70 price target The firm says atacicept “sets a high ...

UK MHRA grants marketing authorization to sparsentan to treat adult patients with primary immunoglobulin A nephropathy: United Kingdom Wednesday, November 20, 2024, 14:00 Hrs [IST ...

糖皮质激素：在经过90天的优化支持治疗后，如尿蛋白仍高于1g/24h，则应考虑对高风险患者为期6个月的糖皮质激素治疗。副作用：向心性肥胖、骨质疏松、免疫力下降、血糖升高、消化道溃疡、电解质紊乱等。

A team of Japanese researchers has found a class of diabetes drugs that help the kidneys to flush out glucose and maintain kidney health. While Ty ...

As the number of people with diabetes rises, so too does the incidence of diabetic nephropathy, a leading cause of kidney ...

(OPDC) and Otsuka Pharmaceutical, Co. Ltd. (Otsuka) announce the decision to submit a Biologics License Application (BLA) in the U.S. for sibeprenlimab, an investigational drug for the treatment of ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) on Monday approved the medicine Filspari (sparsentan) ...